ApprovalTrail

Approval · Notice of Compliance 7935 · 2006

INFERGEN: Notice of Compliance 7935

Issued May 9, 2006

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
7935
Date
May 9, 2006
Company
Valeant Canada LpLaval, Quebec, Canada
Product type
Biologic
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Manufacturer name change
Therapeutic class
Biological response modifier

Products in this notice

BrandDINStatus today
INFERGEN02239832Cancelled Post Market

Medicinal ingredients